Barts Life Sciences supporting real-world evaluation of new AI heart failure screening tool
Barts Life Sciences is playing a central role in bringing a pioneering new AI screening tool closer to routine NHS use. Developed by clinicians and researchers at Barts Health and Queen Mary University of London, the Intelligent Heart Evaluation Framework (iHeF) uses a simple electrocardiogram (ECG) to detect subtle changes in heart function that currently require specialist hospital imaging. Backed by £1.3m from the National...